At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
cholestyramine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 14, 2016
In Brief
A Phase 3 clinical trial evaluating cholestyramine and diet, fat-restricted for Cardiovascular Diseases and 3 related conditions. Completed.
Detailed Summary
To determine whether reduction of cholesterol by drug therapy significantly lowered the atherosclerotic coronary heart disease rate in a group of hypercholesterolemic but otherwise healthy men. Total dollars spent on the CPPT from June 1973 were $142,250,000. We do not have a year-by-year breakdown.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
19721973197419751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 1973
Study CompletionOct 1989
First PostedOct 1999
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartJun 1, 1973
Study CompletionOct 1, 1989
TodayJul 2, 2026
Posted 26.7 years ago
Interventions
cholestyraminedrug
diet, fat-restrictedbehavioral